ngscho | 1023
NGS Cholangiocellular Carcinoma
Keywords:
Bile Duct Cancer
Cholangiocarcinoma
FGFR1
FGFR2
FGFR3
FGFR4
IDH1
Next Generation Sequencing
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Variants Hotspot: FGFR1, FGFR2, FGFR3, FGFR4, IDH1; Fusions: FGFR1, FGFR2, FGFR3, FGFR4 and other pathogenic variants. To order this analysis, please contact the Customer Service Center: contact@viollier.ch or 0848 121 121.This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tarmed. |
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|